The Inventurus Knowledge Solutions IPO is being offered as a book-built issue of 1.88 crore shares. The issue consists entirely of an offer for sale of 1.88 crore shares.
The subscription for the Inventurus Knowledge Solutions IPO is scheduled to open on December 12, 2024, and will close on December 16, 2024. The allotment is expected to be finalized on Tuesday, December 17, 2024. A listing of the Inventurus Knowledge Solutions IPO is planned on BSE and NSE, with the tentative listing date set as Thursday, December 19, 2024.
The price bands for the Inventurus Knowledge Solutions IPO have not yet been announced.
Get the Inventurus Knowledge Solutions IPO RHP for detailed information.
| IPO Date | December 12, 2024 to December 16, 2024 |
| Listing Date | December 19, 2024 |
| Face Value | ₹ 1 / Share |
| Price Band | ₹ 1265 to ₹ 1329 / Share |
| Lot Size | 11 Shares |
| Total Issue Size | ₹2,497.92 Cr |
| Fresh Issue | ₹2,497.92 Cr |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 171,573,159 |
| Share holding post issue | 171,573,159 |
| Market Maker portion |
Inventurus Knowledge Solutions Limited IPO opens on December 12, 2024, and closes on December 16, 2024.
| IPO Open Date | December 12, 2024 |
| IPO Close Date | December 16, 2024 |
| Basis of Allotment | December 17, 2024 |
| Initiation of Refunds | December 18, 2024 |
| Credit of Shares to Demat | December 18, 2024 |
| Listing Date | December 19, 2024 |
| Cut-off time for UPI mandate confirmation | December 16, 2024 |
A minimum of 11 shares can be bid for by investors, with additional bids required in multiples thereof. The table below is used to depict the minimum and maximum investments for retail investors and HNIs, shown in terms of shares and amounts.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 11 | Rs.14,619 |
| Retail (Max) | 13 | 143 | Rs.190,047 |
| S-HNI (Min) | 14 | 154 | Rs.204,666 |
| S-HNI (Max) | 68 | 748 | Rs.994,092 |
| B-HNI (Min) | 69 | 759 | Rs.1,008,711 |
| HNI (Min) |
| Share Holding Pre Issue | 69.73% |
| Share Holding Post Issue |
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | |
|
| Other Shares Offered | |
|
| QIB Shares Offered | Not less than 75% of the Offer |
|
| NII (HNI) Shares Offered | Not more than 15% of the Offer |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | Not more than 10% of the Offer |
|
| Employee Shares Offered | |
|
| Total Shares Offered | |
| Bid Date | |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | |
| Anchor lock-in period end date for 50% shares (30 Days) | |
| Anchor lock-in period end date for remaining shares (90 Days) |
Incorporated in 2006, Inventurus Knowledge Solutions Limited (IKS Health) is known for providing services to healthcare enterprises, with administrative tasks and paperwork being handled for doctors and other healthcare providers. Services such as clinical support, medical documentation management, virtual medical scribing, and others are offered by the company.
Healthcare enterprises are supported by IKS Health in outpatient and inpatient care through its platform. Patients are assisted in receiving care more efficiently, while the administrative burden on healthcare providers is reduced.
Outpatient service facilities, also referred to as ambulatory care, are characterized by the provision of medical care without requiring hospital admission. Services such as observation, consultation, diagnosis, rehabilitation, intervention, and treatment are included.
Inpatient care is defined by the provision of medical treatment to patients who are admitted to a hospital or medical facility, requiring either an overnight stay or an extended duration.
As of September 30, 2024, over 778 healthcare organizations, including health systems, multi-specialty medical groups, and other outpatient and inpatient providers, are served by IKS. Key clients such as Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management are included among its partnerships.
A team of more than 13,528 employees, including 2,612 clinically-trained professionals, is employed by the company. Additionally, a consultative sales force is operated across the US, Canada, and Australia.
| KPI | Values |
|---|---|
| ROE | 32% |
| ROCE | 31.56% |
| Debt/Equity | -0.06 |
| RoNW | 32% |
| P/BV | |
| PAT Margin (%) | 20.38 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 21.59 | 21.59 |
| P/E (x) |
No proceeds from the Offer will be received by the company, as all such proceeds, net of any Offer-related expenses to be borne by the Selling Shareholders, will be directed to the Selling Shareholders.
Inventurus Knowledge Solutions Limited Building No. 5 & 6, Unit No. 801, 8th Floor, Mindspace SEZ, Thane Belapur Road, Airoli, Navi Mumbai, Thane, 400708 Phone: +91 22 3964 3205 Email: company.secretary@ikshealth.com Website: https://ikshealth.com/ |
Link Intime India Private Ltd Phone: +91-22-4918 6270 Email: ikshealth.ipo@linkintime.co.in Website: https://linkintime.co.in/initial_offer/public-issues.html |
Lamfindia specializes in offering innovative financial solutions, including stock broker services, mutual fund investments, and IPO guidance.